| [1] |
Dholaria B, Savani BN, Hamilton BK, et al.
Hematopoietic cell transplantation in the treatment of newly diagnosed adult acute myeloid leukemia: an evidence-based review from the American society of transplantation and cellular therapy[J]. Transplant Cell TherTransplant Cell Ther, 2021, 27(1): 6-20.
doi: 10.1016/j.bbmt.2020.09.020 |
| [2] |
Percival ME, Lai C, Estey E, et al.
Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia[J]. Blood RevBlood Rev, 2017, 31(4): 185-192.
doi: 10.1016/j.blre.2017.01.003 |
| [3] |
Abelson S, Collord G, Ng SWK, et al.
Prediction of acute myeloid leukaemia risk in healthy individuals[J]. NatureNature, 2018, 559(7714): 400-404.
doi: 10.1038/s41586-018-0317-6 |
| [4] |
Zhou WL, Wu HB, Wang LJ, et al.
Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia[J]. Eur J RadiolEur J Radiol, 2016, 85(1): 205-210.
doi: 10.1016/j.ejrad.2015.11.019 |
| [5] |
de Bonilla Damiá Á, Fernández López R, Acevedo Báñez I, et al. 18F-FDG PET/CT for extramedullary relapse of acute leukemia of ambiguous lineage[J/OL]. Rev Esp Med Nucl Imagen Mol (Engl Ed), 2019, 38(6): 395−396[2020-10-21]. https://www.sciencedirect.com/science/article/abs/pii/S2253654X18302877?via%3Dihub. DOI: 10.1016/j.remn.2019.01.009. |
| [6] |
Stölzel F, Lüer T, Löck S, et al.
The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the prospective PETAML trial[J]. HaematologicaHaematologica, 2020, 105(6): 1552-1558.
doi: 10.3324/haematol.2019.223032 |
| [7] |
Arimoto MK, Nakamoto Y, Nakatani K, et al. Increased bone marrow uptake of 18F-FDG in leukemia patients: preliminary findings[J/OL]. Springerplus, 2015, 4: 521[2020-10-21]. https://springerplus.springeropen.com/articles/10.1186/s40064-015-1339-2. DOI: 10.1186/s40064-015-1339-2. |
| [8] |
Alam MS, Fu L, Ren YY, et al.
18F-FDG super bone marrow uptake: a highly potent indicator for the malignant infiltration[J]. Medicine (Baltimore)Medicine (Baltimore), 2016, 95(52): e5579-.
doi: 10.1097/MD.0000000000005579 |
| [9] |
中华医学会血液学分会白血病淋巴瘤学组.
复发难治性急性髓系白血病中国诊疗指南(2017年版)[J]. 中华血液学杂志中华血液学杂志, 2017, 38(3): 183-184.
doi: 10.3760/cma.j.issn.0253-2727.2017.03.002 Leukemia and Lymphoma Group, Branch of Hematology, Chinese Medical Association. The guidelines for diagnosis and treatment of acute myelogenous leukemia (relapse/refractory) in China (2017)[J]. Chin J HematolChin J Hematol, 2017, 38(3): 183-184. doi: 10.3760/cma.j.issn.0253-2727.2017.03.002 |
| [10] |
中华医学会血液学分会干细胞应用学组.
中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅲ)——急性移植物抗宿主病(2020年版)[J]. 中华血液学杂志中华血液学杂志, 2020, 41(7): 529-536.
doi: 10.3760/cma.j.issn.0253-2727.2020.07.001 Stem Cell Application Group of Hematology Branch of Chinese Medical Association. Chinese consensus of allogeneic hematopoietic stem cell transplantation for hematological disease (Ⅲ)—acute graft-versus-host disease (2020)[J]. Chin J HematolChin J Hematol, 2020, 41(7): 529-536. doi: 10.3760/cma.j.issn.0253-2727.2020.07.001 |
| [11] |
Zhao ZX, Hu YE, Li JH, et al.
Applications of PET in diagnosis and prognosis of leukemia[J]. Technol Cancer Res TreatTechnol Cancer Res Treat, 2020, 19(19): 1-12.
doi: 10.1177/1533033820956993 |
| [12] |
Zhang SX, Wang W, Kan Y, et al.
Extramedullary infiltration of acute lymphoblastic leukemia in multiple organs on FDG PET/CT[J]. Clin Nucl MedClin Nucl Med, 2018, 43(3): 217-219.
doi: 10.1097/RLU.0000000000001964 |
| [13] |
李河北, 王茜, 赵赟赟, 等.
18F-FDG PET/CT对急性白血病髓内及髓外复发的诊断[J]. 中国医学影像学杂志中国医学影像学杂志, 2018, 26(2): 140-143, 147.
doi: 10.3969/j.issn.1005-5185.2018.02.015 Li HB, Wang Q, Zhao YY, et al. Diagnosis of 18F-FDG PET/CT in intra and extramedullary relapse of acute leukemia[J]. Chin J Med ImagingChin J Med Imaging, 2018, 26(2): 140-143, 147. doi: 10.3969/j.issn.1005-5185.2018.02.015 |
| [14] |
Wang XX, Huang XY, Zhang LJ, et al.
Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma[J]. Med Clín (Barc)Med Clín (Barc), 2020, 154(2): 61-65.
doi: 10.1016/j.medcli.2019.07.022 |
| [15] |
Yousefi-Koma A, Shiravand Y, Qutbi M, et al.
Diffuse skeletal uptake on 18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan in a patient with acute lymphoblastic leukemia: a typical superscan pattern resembling NaF positron emission tomography scan[J]. Indian J Nucl MedIndian J Nucl Med, 2019, 34(4): 326-328.
doi: 10.4103/ijnm.IJNM_106_19 |
| [16] |
Sachpekidis C, Mai EK, Goldschmidt H, et al.
18F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate[J]. Clin Nucl MedClin Nucl Med, 2015, 40(6): e300-e307.
doi: 10.1097/RLU.0000000000000773 |
| [17] |
Su K, Nakamoto Y, Nakatani K, et al.
Diffuse homogeneous bone marrow uptake of FDG in patients with acute lymphoblastic leukemia[J]. Clin Nucl MedClin Nucl Med, 2013, 38(1): e33-e34.
doi: 10.1097/RLU.0b013e3182485277 |
| [18] |
Yi C, Shi XC, Wang XY, et al.
The alteration of 18F-FDG uptake in bone marrow after treatment with interleukin 11[J]. Clin Nucl MedClin Nucl Med, 2014, 39(10): 934-935.
doi: 10.1097/RLU.0000000000000491 |
| [19] |
Chen YK, Yeh CL, Tsui CC, et al.
F-18 FDG PET for evaluation of bone marrow involvement in non-Hodgkin lymphoma: a meta-analysis[J]. Clin Nucl MedClin Nucl Med, 2011, 36(7): 553-559.
doi: 10.1097/RLU.0b013e318217aeff |
| [20] |
Nakajo M, Jinnouchi S, Inoue H, et al.
FDG PET findings of chronic myeloid leukemia in the chronic phase before and after treatment[J]. Clin Nucl MedClin Nucl Med, 2007, 32(10): 775-778.
doi: 10.1097/RLU.0b013e318148b467 |
| [21] |
Janssens AM, Offner FC, Van Hove WZ, et al.
Bone marrow necrosis[J]. CancerCancer, 2000, 88(8): 1769-1780.
doi: 10.1002/(SICI)1097-0142(20000415)88:8<1769::AID-CNCR3>3.0.CO;2-H |
| [22] |
尹吉林, 王欣璐, 张金赫, 等.
18F-FDG PET/CT显像全身骨髓代谢弥漫增高原因分析[J]. 中华核医学杂志中华核医学杂志, 2011, 31(3): 151-154.
doi: 10.3760/cma.j.issn.0253-9780.2011.03.002 Yin JL, Wang XL, Zhang JH, et al. Analysis on the reasons for diffuse 18F-FDG uptake by bone marrow using whole-body PET/CT[J]. Chin J Nucl MedChin J Nucl Med, 2011, 31(3): 151-154. doi: 10.3760/cma.j.issn.0253-9780.2011.03.002 |
| [23] |
Adams HJA, Kwee TC, Fijnheer R, et al.
Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?[J]. Ann Nucl MedAnn Nucl Med, 2015, 29(2): 132-137.
doi: 10.1007/s12149-014-0920-z |
| [24] |
St-Pierre F, Broski S, Laplant B, et al.
Maximizing FDG-PET/CT utility in staging of follicular lymphoma (FL): the role of spleen involvement and bone standardized uptake values[J]. BloodBlood, 2019, 134(S1): S2811-.
doi: 10.1182/blood-2019-131992 |
| [25] |
Kaya Z, Akdemir OU, Atay OL, et al.
Utility of 18-fluorodeoxyglucose positron emission tomography in children with relapsed/refractory leukemia[J]. Pediatr Hematol OncolPediatr Hematol Oncol, 2018, 35(7/8): 393-406.
doi: 10.1080/08880018.2018.1557306 |